This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LYMPHNODES_SECONDARY_NAS_EXALLC for full statistics.
Secondary and unspecified malignant neoplasm of lymph nodes
C3_LYMPHNODES_SECONDARY_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3196 |
4. Check minimum number of eventsNone |
3196 |
5. Include endpointsNone |
3196 |
6. Filter based on genotype QC (FinnGen only) |
3196 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Secondary and unspecified malignant neoplasm of lymph nodes
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm
- Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3196 | 1424 | 1772 |
| Unadjusted period prevalence (%) | 0.65 | 0.49 | 0.78 |
| Median age at first event (years) | 61.47 | 59.55 | 63.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2919
- Matched controls
- 29191
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4BD
NOMESCO Finland
Extensive body CT
10.0
323.0
1172
1835
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
159.0
323.0
2101
463
M04AA01
ATC
allopurinol; systemic
8.3
323.0
1249
2413
A04AA01
ATC
ondansetron; systemic, rectal
10.5
323.0
689
833
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
72.2
323.0
552
94
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
43.8
323.0
901
294
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
21.8
323.0
836
528
L03AA13
ATC
pegfilgrastim; parenteral
18.8
323.0
597
393
XW000
NOMESCO Finland
Bone marrow biopsy
20.0
323.0
811
551
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
94.3
323.0
704
98
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
343
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
87.3
323.0
536
75
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
138.8
323.0
877
90
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
145.9
323.0
392
31
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
36.2
323.0
589
202
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
1186.4
323.0
409
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
324.1
323.0
531
20
A03FA01
ATC
metoclopramide; systemic, rectal
8.7
323.0
1586
3496
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
42.6
323.0
477
133
L03AA02
ATC
filgrastim; parenteral
43.8
323.0
793
246
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
1132.9
317.5
305
*
JN6AD
NOMESCO Finland
CT of torso and neck
44.3
286.2
356
91
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.5
237.5
563
797
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
178.1
235.9
245
15
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
231.4
219
*
JN4AD
NOMESCO Finland
Body CT examination
6.8
226.5
636
1153
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
248.3
225.3
229
10
WW500
NOMESCO Finland
Blood transfusion
10.4
219.5
457
512
A04AA02
ATC
granisetron; systemic, transdermal
7.8
218.9
548
838
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
44.5
209.2
260
64
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
282.9
208.0
210
8
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
76.1
204.4
232
33
1XC02
NOMESCO Finland
NA
52.6
204.4
246
51
C83.1
ICD-10 Finland
Mantle cell lymphoma
145.3
192.1
203
15
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
26.3
191.9
271
113
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
31.0
185.1
250
88
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
84.4
182.1
204
26
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.3
179.0
394
480
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
176.9
168
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
312.0
173.9
175
6
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
43.4
173.7
217
54
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
453.8
173.7
172
*
ZX120
NOMESCO Finland
Intravenous
5.1
172.9
619
1467
EP1AE
NOMESCO Finland
Neck ultrasound examination
7.0
168.5
450
739
C83.00
ICD-10 Finland
Lymphocytic lymphoma
197.9
162.6
168
9
H02AB06
ATC
prednisolone; systemic
2.9
162.0
1748
9899
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.3
161.9
356
430
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
102.8
159.0
174
18
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
158.9
657
1793
R50.9
ICD-10 Finland
Fever, unspecified
3.9
150.9
731
2297
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
44.1
149.5
186
45
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
75.0
149.5
170
24
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
127.5
146.7
157
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
143.7
1277
6227
D70.82
ICD-10 Finland
Drug-induced neutropenia
16.1
142.8
238
160
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
16.4
138.3
229
151
H02AB02
ATC
dexamethasone; systemic
4.3
134.7
571
1572
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
32.6
133.8
178
58
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
133.3
127
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
131.2
125
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.3
130.6
375
668
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.1
129.6
228
174
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
129.0
665
2167
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
+∞
128.1
122
*
L03AA14
ATC
lipegfilgrastim; parenteral
14.6
124.1
215
158
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
119.6
114
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
115.8
1593
9574
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
12.7
110.2
203
171
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
14.7
109.1
188
136
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
105.9
101
*
H02AB07
ATC
prednisone; oral
3.2
105.6
662
2461
A02BC02
ATC
pantoprazole; systemic
2.4
104.3
2054
14461
ZX112
NOMESCO Finland
Subcutaneous
10.3
100.9
206
213
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
18.4
100.9
159
91
XX9CD
NOMESCO Finland
Very extensive complementary CT
253.3
96.2
98
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
13.8
93.5
165
126
N02AA05
ATC
oxycodone; systemic
3.0
93.3
641
2513
WW300
NOMESCO Finland
Transfer of autologic stem cells
43.0
89.9
112
27
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
87.9
84
*
20199
ICD-8 Finland
Hodgkin's disease
+∞
85.8
82
*
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
85.8
82
*
212
Kela drug reimbursment
Gout
8.0
83.6
197
260
J05AB11
ATC
valaciclovir; oral
3.0
82.8
542
2037
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
172.9
80.5
84
5
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
210.8
79.7
82
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.8
79.6
239
442
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.7
77.7
207
327
J01MA12
ATC
levofloxacin; systemic
2.5
74.7
735
3505
L01AA02
ATC
chlorambucil; oral
40.4
74.6
94
24
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.2
70
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
73.2
70
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
13.5
71.1
126
97
B72
ICPC
Hodgkin Lymphoma
128.2
70.2
75
6
WF002
NOMESCO Finland
Radical radiotherapy
4.1
68.5
289
764
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
66.9
64
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.9
64
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
70.8
66.5
76
11
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.8
65.9
307
884
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.8
64.5
193
354
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
14.6
62.5
107
76
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
61.7
59
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
60.4
777
4154
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
59.6
57
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.9
58.5
203
441
Z51.5
ICD-10 Finland
Palliative care
3.5
56.6
282
855
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
23.5
55.5
80
35
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.5
55.5
173
333
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
27.8
55.4
76
28
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.4
53
*
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.4
53
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
54.6
881
5145
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
54.3
52
*
XX3DW
NOMESCO Finland
Time consuming IT work
2.7
54.2
409
1648
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
54.1
839
4816
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.2
50
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
259.7
50.2
51
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.0
49.6
126
186
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
9.8
49.5
102
107
JN4CD
NOMESCO Finland
Very extensive body CT
4.1
48.9
203
525
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.0
48.5
87
69
B01AB05
ATC
enoxaparin; parenteral
1.9
48.3
947
5891
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
48.0
46
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
40.8
48.0
60
15
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
28.9
47.9
65
23
4701
FHL
Neck lymph node removal
52.8
47.8
57
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
47.8
692
3830
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.7
47.6
371
1519
TGC00
NOMESCO Finland
Bronchial lavation
4.9
47.0
161
344
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.5
47.0
173
399
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
13.1
46.6
83
65
WZC30
NOMESCO Finland
Teaching
2.3
46.0
469
2214
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.3
45.5
244
780
1AA09
NOMESCO Finland
NA
233.5
45.1
46
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.9
43
*
WW409
NOMESCO Finland
Other aferesis
34.2
43.9
57
17
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
119.4
43.8
47
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
8.1
43.5
100
127
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.8
43.0
94
110
WW402
NOMESCO Finland
Leucoferesis
152.3
42.9
45
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.1
42.5
107
156
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
423.5
42.3
42
*
WF004
NOMESCO Finland
Palliative radiotherapy
5.5
42.0
128
240
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
41.5
598
3276
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
33.7
40.7
53
16
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.1
40.7
240
820
ZX108
NOMESCO Finland
Inhalation
12.4
40.7
74
61
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
142.0
39.8
42
*
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
39.7
38
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
39.6
390
1800
WX110
NOMESCO Finland
Local anesthesy
1.7
39.5
1854
14799
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
39.4
533
2842
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.2
39.2
221
731
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
44.3
39.1
48
11
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
202.6
38.9
40
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.5
38.3
116
216
L01CB01
ATC
etoposide; systemic
16.4
37.7
61
38
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
15.9
37.4
61
39
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
34.8
37.2
48
14
A07AA02
ATC
nystatin; oral
2.8
36.8
248
922
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
101.4
36.8
40
*
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
36.5
35
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
36.3
281
1135
YNB10
NOMESCO Finland
Collection of stem cells for transplant
98.8
35.8
39
*
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
53.2
35.4
42
8
A04AD12
ATC
aprepitant; systemic
5.5
34.8
106
199
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
96.2
34.8
38
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
34.6
167
491
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.3
34.6
94
153
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.4
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.4
33
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
34.4
172
520
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
22.1
34.4
50
23
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
18.0
34.0
53
30
J05AB01
ATC
aciclovir; systemic
1.9
33.8
602
3542
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
33.4
32
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.5
32.8
100
188
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
171.9
32.8
34
*
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
118.0
32.7
35
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
32.2
2411
21229
C81
ICD-10 Finland
Hodgkin lymphoma
320.4
31.9
32
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
31.3
30
*
JAH21
NOMESCO Finland
Staging laparoscopy
+∞
31.3
30
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
31.3
30
*
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
31.3
30
*
A04AA55
ATC
palonosetron, combinations; systemic
4.4
31.0
116
272
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
10.4
29.9
59
58
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
305.4
29.8
30
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
29.7
340
1672
FM1FN
NOMESCO Finland
Heart function isotope examination
13.2
29.6
52
40
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
29.2
28
*
TPX15
NOMESCO Finland
Removal of vascular injection port
14.2
28.9
49
35
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
28.2
27
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
28.2
27
*
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
28.2
27
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
27.9
294
1390
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.6
27.8
214
860
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
101.0
27.7
30
*
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
146.4
27.7
29
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
146.4
27.7
29
*
C03CA01
ATC
furosemide; systemic
1.6
27.2
881
6147
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
27.2
1325
10224
C82
ICD-10 Finland
Follicular lymphoma
+∞
27.1
26
*
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
+∞
27.1
26
*
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
27.1
26
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
38.2
27.1
34
9
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
26.8
341
1748
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
273.5
26.8
27
*
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
273.5
26.8
27
*
Z31.6
ICD-10 Finland
General counselling and advice on procreation
11.0
26.3
50
46
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
26.1
25
*
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
26.1
25
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.1
25
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
12.2
26.0
47
39
JAH20
NOMESCO Finland
Staging laparotomy
262.8
25.7
26
*
B02
ICPC
Lymph gland(s) enlarged/painful
9.4
25.7
53
57
JAH00
NOMESCO Finland
Laparotomy
3.7
25.1
112
310
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.0
24
*
L01BB05
ATC
fludarabine; systemic
26.4
24.8
34
13
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
70.5
24.8
28
*
TAB00
NOMESCO Finland
Lumbar puncture
3.0
24.7
149
517
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
131.1
24.6
26
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
24.3
1060
7907
C82.7
ICD-10 Finland
Other types of follicular lymphoma
56.5
24.0
28
5
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
16.7
24.0
38
23
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.0
23
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.0
23
*
B01AB10
ATC
tinzaparin; parenteral
2.3
23.8
224
1002
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.2
23.7
129
417
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
31.3
23.7
31
10
C83.71
ICD-10 Finland
Burkitt's tumour
241.8
23.7
24
*
WX402
NOMESCO Finland
General anaesthesia
1.8
23.6
441
2602
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
10.9
23.6
45
42
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
23.4
796
5583
D69.5
ICD-10 Finland
Secondary thrombocytopenia
14.6
23.4
39
27
WW200
NOMESCO Finland
Immunization
3.4
23.3
117
356
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
28.5
23.1
31
11
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.4
22.3
111
336
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
10.9
22.1
42
39
J01MA14
ATC
moxifloxacin; systemic
2.1
22.1
273
1381
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
21.7
296
1559
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
21.7
275
1406
R06AE07
ATC
cetirizine; oral
1.5
21.7
1079
8228
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
21.7
112
349
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.5
21.6
47
56
J01DB01
ATC
cefalexin; oral
1.5
21.6
2209
19566
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.5
21.4
177
739
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
6.6
21.3
55
85
H02AB09
ATC
hydrocortisone; systemic
3.9
21.1
89
236
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
21.0
221
1042
GEA00
NOMESCO Finland
Mediastinoscopy
11.3
20.9
39
35
WX002
NOMESCO Finland
Sedation and analgesia
1.7
20.9
546
3561
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
20.9
20
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
20.9
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.9
20
*
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.9
20
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
20.9
20
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
20.8
319
1755
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.9
20.7
86
225
390
Kela drug reimbursment
Ibrutinib
30.3
20.5
27
9
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
20.5
152
598
ZXA00
NOMESCO Finland
Right side
1.5
20.1
762
5450
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
8.7
20.1
43
50
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
19.8
19
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.1
19.6
48
69
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.2
18.9
72
174
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
14.9
18.9
31
21
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.8
18.8
63
134
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
18.8
70
166
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.8
18
*
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.8
18
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.8
18
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
18.7
254
1332
C83.8
ICD-10 Finland
Other non-follicular lymphoma
191.1
18.5
19
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.1
18.4
105
352
B02.9
ICD-10 Finland
Zoster without complication
2.3
18.2
179
816
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
44.3
18.2
22
5
A79
ICPC
Malignancy NOS
4.8
18.2
61
130
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
13.8
17.7
30
22
3AA13
NOMESCO Finland
NA
20.2
17.7
26
13
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.7
17
*
ZXA05
NOMESCO Finland
Left side
1.5
17.7
698
5014
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
17.6
126
488
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
181.0
17.5
18
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
181.0
17.5
18
*
E83.50
ICD-10 Finland
Hypercalcemia
4.9
17.5
57
118
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.2
17.4
54
106
JAH01
NOMESCO Finland
Laparoscopy
2.7
17.4
124
480
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
6.8
17.2
43
64
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
12.6
17.1
30
24
KA1FN
NOMESCO Finland
Isotope renography
7.2
17.0
41
58
HA1AA
NOMESCO Finland
X-ray mammography
2.1
16.9
187
901
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.7
16.9
75
209
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
4.2
16.7
63
152
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
16.7
16
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
16.7
16
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.3
16.6
85
265
1512
Kela drug reimbursment
Ibrutinib
27.7
16.5
22
8
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.8
16.5
41
61
JN4DD
NOMESCO Finland
Scout CT scan of torso
20.1
16.4
24
12
L01XE27
ATC
[U] ibrutinib; oral
40.3
16.3
20
5
Z52.89
ICD-10 Finland
Donor of other organ or tissue
40.3
16.3
20
5
A02BC01
ATC
omeprazole; systemic
1.5
16.1
725
5340
JMA10
NOMESCO Finland
Transabdominal total splenectomy
8.6
15.9
34
40
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
15.7
15.7
25
16
R4190
NOMESCO Finland
Nutritional therapy
2.9
15.7
98
351
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.1
15.7
85
277
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.6
15
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
J02AC03
ATC
voriconazole; systemic
11.8
15.5
28
24
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
14.8
15.3
25
17
ED1AA
NOMESCO Finland
Mandipular X-ray examination
7.1
15.3
37
53
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
13.1
15.2
26
20
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
15.1
511
3529
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
14.8
212
1132
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.6
14.8
67
191
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.0
14.7
196
1022
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.3
14.7
73
223
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
150.7
14.5
15
*
127
Kela drug reimbursment
Transplant complication
3.9
14.5
58
149
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.8
14.3
90
324
5702
FHL
Local lymph node removal (eg armpit, groin)
11.4
14.3
26
23
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
14.2
664
4908
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
14.2
462
3158
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
42.7
14.1
17
*
1CX01
NOMESCO Finland
NA
15.8
13.9
22
14
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
13.8
390
2575
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
13.8
806
6218
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
13.6
921
7285
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
13.5
13
*
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
+∞
13.5
13
*
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
+∞
13.5
13
*
6753
FHL
Transabdominal splenectomy
34.2
13.5
17
5
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
34.2
13.5
17
5
372
Kela drug reimbursment
Idelalisib
140.6
13.5
14
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
140.6
13.5
14
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.1
13.3
73
241
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.0
13.1
75
252
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.9
13.1
53
138
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
15.1
13.1
21
14
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
5.4
13.0
38
71
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
12.9
84
309
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.9
12.8
35
60
9101
FHL
Bone biopsy
11.6
12.8
23
20
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
14.1
12.7
21
15
120
Kela drug reimbursment
Hypogammaglobulinaemia
14.1
12.7
21
15
V03AF03
ATC
calcium folinate; systemic
12.3
12.6
22
18
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
+∞
12.5
12
*
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
+∞
12.5
12
*
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
10.1
12.5
24
24
C85.0
ICD-10 Finland
Lymphosarcoma
130.5
12.4
13
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.5
12.3
96
393
H03AA01
ATC
levothyroxine sodium; systemic
1.5
12.2
536
3898
A06AD11
ATC
lactulose; oral
1.5
12.1
392
2667
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.4
12.1
21
17
4704
FHL
Neck tumor removal
21.4
12.0
17
8
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
13.4
11.9
20
15
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
11.9
146
739
R4110
NOMESCO Finland
Physiotherapy
1.4
11.7
656
4993
L01EL01
ATC
ibrutinib; oral
30.1
11.6
15
5
9109
FHL
Other measure in this category
23.0
11.6
16
7
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
11.1
11.5
21
19
A41.8
ICD-10 Finland
Other specified sepsis
3.2
11.5
59
187
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
11.5
11
*
9590/3-C77.9
ICD-O-3
Malignant lymphoma, NOS, of lymph node, NOS
+∞
11.5
11
*
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
120.4
11.4
12
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.0
11.4
139
702
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
2.6
11.4
84
334
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
11.8
11.3
20
17
L01AA01
ATC
cyclophosphamide; systemic
6.6
11.2
28
43
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.9
11.2
30
51
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.5
11.1
38
85
N05CF01
ATC
zopiclone; oral
1.4
11.1
816
6495
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
6.4
11.1
28
44
A04AA03
ATC
tropisetron; systemic
8.1
11.1
24
30
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.4
11.0
32
60
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
15.5
10.8
17
11
S04
ICPC
Lump/swelling localized
1.7
10.8
221
1335
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.2
10.8
56
180
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
10.7
97
429
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.8
10.6
44
118
B59
ICD-10 Finland
Pneumocystosis
60.2
10.6
12
*
EMA10
NOMESCO Finland
Biopsy of tonsil
8.5
10.5
22
26
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
10.1
10.5
20
20
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
10.5
520
3865
J01CA04
ATC
amoxicillin; systemic
1.3
10.5
2060
18825
J02AC01
ATC
fluconazole; systemic
1.3
10.4
828
6659
L01XX47
ATC
[U] idelalisib; oral
110.4
10.4
11
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
110.4
10.4
11
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
+∞
10.4
10
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.8
10.3
42
112
JAL00
NOMESCO Finland
Biopsy of peritoneum
6.6
10.2
25
38
R50.8
ICD-10 Finland
Other specified fever
6.2
10.1
26
42
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
3.0
10.1
55
183
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
2.8
10.1
61
218
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
11.3
10.0
18
16
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
8.5
10.0
21
25
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
10.0
158
881
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.0
10.0
57
193
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
40.2
10.0
12
*
Z51.0
ICD-10 Finland
Radiotherapy session
3.6
9.9
43
121
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
7.6
9.9
22
29
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.2
9.9
102
482
TGD00
NOMESCO Finland
Needle biopsy of lung
5.2
9.8
29
56
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
9.8
220
1364
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
9.7
168
962
R05
ICD-10 Finland
Cough
1.4
9.7
459
3378
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
9.7
143
776
B73
ICPC
Leukaemia
13.4
9.7
16
12
N02AX02
ATC
tramadol; systemic, rectal
1.3
9.7
1070
9006
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
55.2
9.6
11
*
B01AB04
ATC
dalteparin; parenteral
1.9
9.6
135
721
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
9.6
265
1736
EBA10
NOMESCO Finland
Surgical removal of tooth
1.6
9.5
247
1591
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.2
9.5
28
54
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.9
9.5
37
95
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
9.4
83
363
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
5.0
9.4
29
59
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
30.1
9.4
12
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
9.4
9
*
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
1XC12
NOMESCO Finland
NA
+∞
9.4
9
*
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.3
9.3
27
51
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
5.6
9.3
26
47
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
9.3
223
1409
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
9.5
9.3
18
19
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
9.2
153
865
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.9
9.2
55
195
A06AH03
ATC
naloxegol; oral
3.5
9.2
41
118
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
6.0
9.2
24
40
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.6
9.2
39
108
I50.1
ICD-10 Finland
Left ventricular failure
1.9
9.1
137
749
ENA10
NOMESCO Finland
Biopsy of pharynx
7.7
9.1
20
26
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.9
9.0
52
179
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
15.6
9.0
14
9
6BA02
NOMESCO Finland
NA
8.0
8.8
19
24
104
Kela drug reimbursment
Thyroid insufficiency
1.7
8.8
174
1040
A05AA02
ATC
ursodeoxycholic acid; oral
3.1
8.8
45
145
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.4
8.8
73
312
SPAT1153
SPAT
Removal of sutures
1.3
8.8
800
6538
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
8.7
92
440
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
50.1
8.7
10
*
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
50.1
8.7
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
3.5
8.6
38
109
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.9
8.6
34
89
D11.70
ICD-10 Finland
Gland sublingual
8.2
8.6
18
22
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
9.0
8.5
17
19
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
2.2
8.5
83
384
5701
FHL
Local exploration of lymph nodes (includes biopsy)
27.6
8.5
11
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
8.3
178
1090
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
8.3
110
575
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
10.8
8.3
15
14
B04
ICPC
Blood symptom/complaint
7.1
8.2
19
27
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
8.2
794
6531
7842A
ICD-9 Finland
Symptoms involving head and neck, Swelling, mass, or lump in head and neck
14.5
8.2
13
9
Z51.88
ICD-10 Finland
Other specified medical care
2.7
8.2
54
205
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
8.2
52
192
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
6.0
8.1
21
35
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
33.4
8.1
10
*
A07AA09
ATC
vancomycin; oral
3.0
8.1
43
143
S18
ICPC
Laceration/cut
1.3
8.0
1051
8978
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
22.1
8.0
11
5
J01MA02
ATC
ciprofloxacin; systemic
1.3
7.9
969
8208
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.9
852
7104
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
4.9
7.9
24
49
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.2
7.9
73
331
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
3.9
7.8
30
77
WX892
NOMESCO Finland
Monitored bed care
1.6
7.8
192
1219
C07AB07
ATC
bisoprolol; oral
1.3
7.8
1219
10630
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
10.8
7.8
14
13
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
9.4
7.8
15
16
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
9.4
7.8
15
16
ZX080
NOMESCO Finland
Image guided radiotherapy
2.5
7.7
55
220
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.6
7.6
32
89
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
7.6
406
3046
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
25.1
7.6
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
8.9
7.5
15
17
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.3
7.5
65
284
B74
ICPC
Malignant neoplasm blood other
10.0
7.5
14
14
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
7.5
146
872
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.7
7.4
30
81
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
80.3
7.4
8
*
C83.7
ICD-10 Finland
Burkitt lymphoma
80.3
7.4
8
*
2301
FHL
Lumbar puncture in anesthesia or operating room
80.3
7.4
8
*
I88.8
ICD-10 Finland
Other nonspecific lymphadenitis
13.4
7.4
12
9
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.8
7.4
44
158
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
5.6
7.4
20
36
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
5.6
7.4
20
36
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
7.3
7
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
9650/3-C77.3
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
7.3
43
153
L03AA04
ATC
NA
10.9
7.3
13
12
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.5
7.3
31
88
L04AD01
ATC
ciclosporin; systemic
2.6
7.2
48
184
A02BA02
ATC
ranitidine; systemic
1.3
7.2
483
3759
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.7
7.2
155
953
WX720
NOMESCO Finland
Own respiration
1.9
7.2
95
499
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.7
7.1
46
172
L57.0
ICD-10 Finland
Actinic keratosis
1.5
7.1
240
1648
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
7.1
95
501
TK800
NOMESCO Finland
Hemodialysis
2.3
7.1
62
272
R06.0
ICD-10 Finland
Dyspnoea
1.3
7.1
602
4851
WF099
NOMESCO Finland
Other radiotherapy
4.5
7.1
23
51
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.4
7.0
32
96
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
5.8
6.9
18
31
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
6.9
109
613
UJF32
NOMESCO Finland
Coloscopy
1.3
6.9
638
5200
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.6
6.8
46
179
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.6
6.8
163
1034
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
3.8
6.8
26
68
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.7
391
2976
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
22.6
6.7
9
*
Z31.8
ICD-10 Finland
Other procreative management
22.6
6.7
9
*
TQW99
NOMESCO Finland
Other minor procedure on skin
1.7
6.7
123
724
ELB30
NOMESCO Finland
Excision of submandibular gland
4.9
6.7
20
41
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
6.6
31
95
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.6
606
4924
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.4
6.6
16
25
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
6.6
62
284
C09AA05
ATC
ramipril; oral
1.3
6.6
624
5097
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
12.3
6.6
11
9
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.5
6.6
28
80
WX702
NOMESCO Finland
Supraglottic ventilation device
1.8
6.5
113
653
L04AA01
ATC
[U] ciclosporin; systemic
2.7
6.5
40
148
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.6
6.5
148
924
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
5.0
6.5
19
38
A02BC05
ATC
esomeprazole; systemic
1.2
6.5
953
8209
JM2AT
NOMESCO Finland
Biopsy of spleen with ultrasound guidance
70.0
6.4
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
6.4
244
1720
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
7.4
6.4
14
19
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.1
6.4
65
307
23999
ICD-8 Finland
Neoplasm of unspecified nature of other and unspecified organs, Other and unspecified sites
14.3
6.4
10
7
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.2
6.4
58
263
I50.0
ICD-10 Finland
Congestive heart failure
1.5
6.4
184
1220
JFB00
NOMESCO Finland
Partial resection of small intestine
2.5
6.3
45
179
Z10.8
ICD-10 Finland
Routine general health check-up of other defined subpopulations
2.2
6.3
62
288
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
8.2
6.3
13
16
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
5.2
6.3
18
35
ZX114
NOMESCO Finland
Intramuscular
2.8
6.3
38
139
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
5.5
6.3
17
31
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
5.5
6.3
17
31
V03AB28
ATC
NA
+∞
6.2
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
9670/3-C77.4
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg
+∞
6.2
6
*
5609
FHL
Other measure in this category
+∞
6.2
6
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.2
6
*
20018
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum
+∞
6.2
6
*
C779, 9715, 3
ICD-O-3
NA
+∞
6.2
6
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.3
6.2
54
240
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.4
6.2
47
194
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
2.6
6.1
41
159
J01MA01
ATC
ofloxacin; systemic
1.5
6.1
211
1457
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.9
6.1
83
441
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
5.3
6.1
17
32
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
6.1
68
336
ZX121
NOMESCO Finland
Central venous catheter
4.7
6.1
19
41
N03AX16
ATC
pregabalin; oral
1.3
6.0
531
4293
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
394
473
9.36
309.36
1.4
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
261
165
17.14
308.75
3.0
2.0
e6/l
399.6
710.2
5.38
117
75
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
342
149
25.58
307.65
2.3
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1985
3154
14.97
307.65
8.0
4.1
u/l
257.1
243.1
2.24
1927
2976
(3042111) Morphology [Interpretation] in Bone marrow Narrative
525
452
13.70
307.65
1.6
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
255
74
37.36
307.65
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1500
3687
6.78
307.65
1.6
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
955
1896
6.76
307.65
3.9
2.7
g/l
8.7
10.7
26.10
915
1718
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
342
161
23.67
307.65
2.3
2.1
%
14.6
14.2
0.09
148
61
(3019198) Lymphocytes [#/volume] in Blood
2500
13194
5.11
307.65
10.1
5.8
e9/l
2.0
1.9
0.46
2337
11500
(3001604) Monocytes [#/volume] in Blood
2487
12840
5.22
307.65
9.9
5.7
e9/l
0.6
0.6
1.26
2307
10995
(3019069) Monocytes/100 leukocytes in Blood
2408
12158
4.98
307.65
10.9
6.3
%
9.5
8.8
17.86
2338
11330
(3026493) Urate [Moles/volume] in Serum or Plasma
1770
7022
4.41
307.65
5.8
2.7
umol/l
1669.0
5750.6
6.11
1712
6016
(42870588) Differential panel, method unspecified - Blood
2012
8938
4.38
307.65
10.0
5.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2412
12445
4.82
307.65
10.7
6.1
%
26.9
27.2
0.50
2341
11521
(4035726)
1172
2274
7.56
307.65
1.7
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
528
156
40.35
307.65
1.4
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2402
12104
4.96
307.65
10.5
6.0
%
2.8
2.8
0.45
2333
11227
(3013115) Eosinophils [#/volume] in Blood
2513
13333
5.14
307.65
10.8
5.9
e9/l
0.2
0.2
3.87
2342
11588
(3018010) Neutrophils/100 leukocytes in Blood
2386
12261
4.73
307.65
9.9
5.9
%
56.6
57.8
3.81
2315
11415
(3045142) Bone marrow Pathology biopsy report
558
285
23.51
307.65
1.5
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1411
3076
7.42
307.65
1.6
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2492
12903
5.23
307.65
10.0
5.7
e9/l
0.0
0.0
3.25
2314
11054
(40768795) Lymph node Pathology biopsy report
864
199
59.13
307.65
1.5
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
308
187
18.12
307.65
2.4
2.1
%
28.4
45.3
3.63
29
27
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
442
373
13.59
307.65
2.7
2.8
u/ml
9991.3
1655.6
0.89
49
27
(3011412) CD3 cells [#/volume] in Blood
439
217
23.29
307.65
2.7
2.2
e9/l
1.1
1.1
0.16
287
121
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1244
1613
11.99
307.65
1.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
472
483
11.29
307.65
5.0
5.4
iu/ml
374.5
682.2
0.51
70
68
(3022096) Basophils/100 leukocytes in Blood
2380
11768
5.00
307.65
10.3
6.0
%
0.7
0.7
0.32
2308
10931
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
277
141
21.41
307.65
2.9
2.2
e9/l
0.2
0.2
0.07
239
125
(1175426) CD3 cells/100 lymphocytes in Blood
344
166
23.10
307.65
2.3
2.1
%
73.1
71.5
0.53
328
156
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
284
150
20.68
307.65
2.9
2.1
e6/l
548.3
553.2
0.02
238
127
(3017143) Hepatitis C virus Ab [Presence] in Serum
1364
2547
8.60
307.65
1.5
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2597
15015
4.89
297.88
23.7
8.7
e9/l
3.6
4.2
44.51
2439
13011
(3028026) IgM [Mass/volume] in Serum or Plasma
673
1517
5.35
288.41
2.9
1.9
g/l
1.2
1.4
1.38
628
1369
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
233
136
18.40
286.50
3.6
2.5
%
35.7
39.6
0.88
99
45
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2447
13804
4.30
284.05
14.9
6.2
umol/l
10.6
11.9
4.98
2407
13079
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
352
421
9.27
276.52
1.4
1.4
u/ml
112.5
120.8
0.24
84
71
(21494814) CD8 cells/100 lymphocytes in Specimen
182
97
19.84
233.03
2.3
2.1
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
163
67
25.58
232.14
2.4
2.1
%
36.1
27.4
4.10
149
62
(3024561) Albumin [Mass/volume] in Serum or Plasma
2104
11617
3.37
231.82
8.1
4.9
g/l
34.4
35.2
6.93
2032
10787
(3017181) Myelocytes/100 leukocytes in Blood
761
2237
4.15
229.74
5.8
4.1
%
1.1
0.9
0.58
446
664
(3006245) CD3-CD19+ cells/100 cells in Blood
163
69
24.84
229.58
2.4
2.1
%
7.8
9.9
0.71
142
62
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
167
77
22.83
227.46
2.3
2.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
939
3270
3.65
220.72
3.6
2.5
%
1.7
1.8
0.97
875
2876
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1126
4412
3.40
219.51
6.3
3.3
mmol/l
0.8
0.8
1.48
1093
4119
(3023520) Reticulocytes [#/volume] in Blood
766
2446
3.80
203.43
3.7
2.5
e9/l
69.0
69.6
0.15
630
1875
(3021440) Promyelocytes/100 leukocytes in Blood
692
2128
3.87
193.37
5.9
4.1
%
0.2
0.1
1.32
411
609
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
352
641
6.05
187.38
2.4
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
665
2033
3.87
186.95
5.6
3.9
%
0.7
0.6
0.57
321
474
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
358
670
5.89
185.13
2.3
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
299
468
6.95
184.85
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
358
683
5.78
181.28
1.6
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
357
687
5.72
179.05
1.3
1.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
204
211
10.26
177.62
1.7
1.9
mg/l
3.5
4.5
2.25
198
202
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
343
643
5.86
176.86
1.3
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
291
467
6.76
175.51
4.3
3.5
%
1.5
1.5
0.03
243
357
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
295
484
6.61
174.13
2.3
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1489
7687
2.75
167.43
7.7
4.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
272
434
6.76
164.77
1.3
1.3
u/ml
284.7
261.7
0.51
167
264
(3000060) B lymphocytes [#/volume] in Blood
114
45
26.23
164.38
2.2
2.0
e6/l
101.7
187.1
1.08
42
21
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
188
202
9.83
159.02
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1154
5421
2.77
153.35
8.5
4.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2118
13465
2.70
150.28
10.7
6.9
mmol/l
1.2
1.2
9.61
1772
11316
(3025159) Blasts/100 leukocytes in Blood
604
1997
3.50
148.48
5.8
4.2
%
0.1
0.3
0.77
332
515
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
387
940
4.55
146.96
2.4
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
593
1960
3.49
145.66
1.8
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1963
12236
2.57
141.55
9.1
6.1
mmol/l
1.2
1.2
9.85
1885
11043
(3003458) Phosphate [Moles/volume] in Serum or Plasma
863
3626
2.89
140.05
7.1
6.0
mmol/l
1.0
1.0
0.09
836
3364
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
118
78
15.67
135.44
3.6
2.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2711
20138
3.28
133.24
19.0
7.5
u/l
84.3
79.4
4.97
2650
18930
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
248
473
5.60
124.65
1.8
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1541
8966
2.39
123.67
7.4
3.3
mmol/l
2.4
2.4
0.92
1425
7760
(40758558) Short blood count panel - Blood
1235
6530
2.45
122.82
17.5
6.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
624
2345
3.06
122.32
2.6
2.7
g/l
64.0
66.3
8.20
597
2141
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
183
264
7.29
121.29
2.5
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1022
4986
2.54
120.64
5.2
3.0
mmol/l
2.5
2.5
4.33
982
4377
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
217
381
6.04
118.97
1.7
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
187
284
6.93
118.19
2.5
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1396
7937
2.35
116.16
7.3
4.0
ph
7.4
7.4
0.78
357
1529
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
171
241
7.44
115.68
2.5
2.4
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2562
19015
2.75
114.94
6.9
4.1
mm/h
15.2
12.8
9.43
2458
17486
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
165
229
7.54
113.13
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
208
370
5.94
112.43
1.8
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
945
4571
2.52
112.35
2.7
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
189
307
6.48
111.96
4.6
3.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1781
11355
2.28
111.23
16.6
9.9
e9/l
0.0
0.0
1.06
1548
9254
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
263
609
4.62
105.17
1.5
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
213
421
5.35
102.65
1.8
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
205
394
5.49
101.90
1.9
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1852
12269
2.21
101.68
6.2
4.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
524
1969
2.99
101.40
2.2
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
914
4641
2.36
95.16
2.3
1.5
g/l
2.0
2.6
9.07
717
2768
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
119
138
8.92
94.63
4.1
3.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
101
95
10.95
93.57
1.2
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
174
315
5.78
92.15
2.0
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
789
3827
2.41
90.56
2.0
2.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1708
11303
2.10
89.66
10.8
10.1
inr
1.3
1.3
0.72
455
3192
(3032352) Blasts [#/volume] in Cerebral spinal fluid
61
23
27.02
89.02
1.8
2.3
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
163
288
5.91
88.52
4.5
3.4
%
55.0
57.2
0.45
115
180
(3044640) Blood type and Crossmatch panel - Blood
1368
8379
2.11
87.84
4.2
2.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
147
239
6.40
86.82
2.6
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
147
239
6.40
86.82
2.7
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
147
239
6.40
86.82
2.6
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
94
89
10.85
86.67
1.8
2.1
u/ml
5250.1
38480.2
0.46
14
13
(40758292) HTLV I+II Ab panel - Serum
67
35
19.53
86.00
1.6
1.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
86
72
12.25
85.93
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
359
1191
3.27
85.35
2.3
1.9
ug/l
1.9
2.3
0.24
328
1046
(3042631) Mycobacterium sp identified in Specimen
188
402
4.91
82.55
2.1
2.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
668
3162
2.41
79.88
2.4
1.8
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
97
109
9.15
78.98
3.1
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
132
214
6.39
78.14
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
95
107
9.12
77.21
3.2
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
95
107
9.12
77.21
3.2
1.6
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
54
22
24.95
76.58
1.2
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
657
3167
2.35
74.91
2.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
105
140
7.72
74.38
3.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
105
140
7.72
74.38
3.0
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
105
140
7.72
74.38
3.0
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
105
140
7.72
74.38
3.0
1.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1107
6700
2.00
69.46
5.8
4.0
%
88.7
87.1
1.28
1092
6532
(40768804) Tissue Pathology biopsy report
1509
10258
1.89
65.95
2.7
2.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
786
4270
2.11
65.79
3.0
2.1
s
29.6
30.0
0.83
772
4138
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
70
7
102.24
64.10
1.1
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1054
6455
1.94
62.52
4.0
2.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
159
377
4.39
61.30
1.1
1.1
—
—
—
0
0
(44806118)
141
310
4.71
59.74
1.8
1.5
—
—
—
0
0
(44790047)
141
310
4.71
59.74
1.8
1.5
—
—
—
0
0
(44790048)
141
310
4.71
59.74
1.8
1.5
—
—
—
0
0
(44790049)
141
310
4.71
59.74
1.8
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
207
609
3.57
59.03
1.3
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
586
2962
2.20
58.26
5.3
2.7
umol/l
7.8
9.0
0.76
535
2594
(3013826) Glucose [Moles/volume] in Serum or Plasma
2054
15749
1.85
57.90
6.9
4.9
mmol/l
6.7
6.8
2.72
1988
14800
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
98
161
6.25
57.20
2.0
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
117
229
5.27
56.77
2.1
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
334
1330
2.69
56.34
1.8
1.8
g/l
1.7
1.5
2.02
273
1145
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
98
165
6.10
55.81
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
70
81
8.81
55.66
1.5
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
104
187
5.71
55.34
2.0
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
96
161
6.12
54.89
2.0
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
48
32
15.21
54.56
1.5
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
180
511
3.67
54.10
5.9
3.6
%
56.7
58.3
0.79
180
511
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1234
8306
1.79
51.98
3.7
3.1
ng/l
1868.2
1593.3
1.25
1106
7129
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
91
160
5.82
49.57
1.9
1.4
ug/l
3.4
3.0
0.13
81
139
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
200
645
3.24
49.22
1.9
2.0
mg/l
11.8
11.6
0.14
189
587
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
221
757
3.06
49.12
3.2
2.5
g/l
3.9
3.6
1.90
214
713
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
141
375
3.89
46.53
5.6
6.7
mg/l
11.0
12.1
1.79
128
352
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
276
1097
2.66
46.48
1.7
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
276
1098
2.66
46.39
1.7
2.4
g/l
7.5
7.4
0.22
213
835
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
39
24
16.44
46.13
1.5
2.3
mg/l
0.5
1.1
4.19
25
19
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
275
1096
2.65
46.05
1.7
2.4
g/l
3.6
3.8
1.77
211
801
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
175
547
3.33
45.29
1.4
1.3
miu/ml
127.1
224.4
2.19
38
222
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
247
943
2.75
44.97
1.9
2.6
g/l
0.5
1.2
2.74
219
818
(3002582) Erythrocytes [#/volume] in Urine
1202
8283
1.72
44.91
3.6
3.4
e6/l
29.2
84.0
4.88
979
6423
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
226
824
2.88
44.87
1.8
2.4
g/l
0.0
0.0
0.01
214
759
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
83
147
5.77
44.87
1.5
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
83
147
5.77
44.87
1.5
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
223
810
2.88
44.58
1.6
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
259
1023
2.67
44.11
1.8
2.5
g/l
3.4
3.1
3.42
214
819
(3008536) Aspergillus sp Ab [Presence] in Serum
52
57
9.26
43.07
2.8
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
552
3036
1.99
42.64
1.6
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
257
1034
2.62
42.14
1.8
2.4
g/l
8.9
10.4
4.47
229
883
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
50
54
9.39
41.87
1.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
137
391
3.62
40.80
1.1
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1322
9528
1.66
40.57
4.2
3.8
e6/l
132.1
111.5
0.20
1023
6882
(3003694) ABO and Rh group [Type] in Blood
1027
6933
1.71
40.37
1.5
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
47
50
9.53
39.79
1.7
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1100
7588
1.69
39.75
3.6
3.2
e6/l
0.5
0.4
0.11
873
5772
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
218
832
2.74
39.64
1.6
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
520
2869
1.97
39.57
2.8
4.1
ug/l
16.0
22.7
0.54
401
2371
(40768806) Pleura Pathology biopsy report
117
306
3.93
39.52
1.7
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
433
2243
2.08
39.28
8.4
3.9
mmol/l
1.2
1.2
2.28
420
1948
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
206
772
2.78
38.78
1.8
2.4
g/l
0.0
0.0
0.00
195
718
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
256
1074
2.50
38.41
1.9
1.9
u/l
43.6
38.8
2.58
232
929
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
206
782
2.75
37.83
1.8
2.4
g/l
0.0
0.0
0.00
195
719
(3000093) Morphology [Interpretation] in Blood Narrative
106
267
4.07
37.70
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1063
7360
1.67
37.34
3.6
3.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
343
1660
2.19
37.00
1.8
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
219
869
2.63
36.85
1.8
2.3
g/l
35.9
37.7
3.61
202
752
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
65
110
6.01
36.84
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
73
140
5.31
36.25
1.7
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
471
2595
1.96
35.73
8.0
7.6
mmol/l
10.0
10.3
0.48
454
2468
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
621
3762
1.81
34.96
2.4
2.6
%
22.0
22.8
0.55
559
3220
(3031040) Bacteria [#/volume] in Urine by Automated count
2094
17283
1.61
34.48
5.1
4.6
e6/l
532.0
1531.6
1.07
46
261
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
100
261
3.92
33.89
3.2
2.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
220
912
2.52
33.79
2.0
3.5
mg/l
52.5
58.1
0.27
179
733
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
220
913
2.51
33.71
2.0
3.5
mg/l
34.4
70.2
1.48
176
735
(3012441) Differential panel - Pleural fluid
110
308
3.66
33.71
1.9
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
120
358
3.44
33.41
2.6
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
99
262
3.87
32.91
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
569
3415
1.81
32.84
1.4
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
229
983
2.43
32.61
3.5
3.1
u/ml
0.3
0.3
0.02
143
571
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
213
886
2.50
32.47
2.0
3.4
ratio
3.9
2.4
0.29
16
70
(3000991) Gas panel - Venous blood
430
2370
1.94
32.39
7.6
8.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
640
3999
1.75
32.12
2.4
2.5
g/l
2.2
2.3
4.27
601
3699
(3002032) Base excess in Venous blood by calculation
465
2642
1.89
31.92
4.9
3.7
mmol/l
2.0
1.9
0.05
381
2108
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
23
11
21.05
30.31
1.1
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
460
2652
1.86
30.05
5.0
3.7
kpa
5.8
5.8
0.38
451
2561
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
96
266
3.69
29.89
1.4
1.3
u/l
360.5
346.5
0.07
89
255
(3009214) Lutropin [Units/volume] in Serum or Plasma
161
608
2.74
29.83
1.6
1.4
u/l
11.4
9.3
1.05
130
492
(3000850) Epithelial cells [#/volume] in Urine
848
5817
1.62
29.55
2.9
2.6
e6/l
4.7
5.1
0.44
764
5107
(3023199) Leukocytes [#/volume] in Pleural fluid
113
354
3.27
29.13
1.8
1.4
e6/l
1761.1
1788.4
0.03
82
255
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
815
5559
1.63
28.97
2.0
1.8
mg/l
2.0
1.3
2.36
664
4275
(3028308) Erythrocytes [#/volume] in Pleural fluid
106
322
3.37
28.71
1.7
1.4
e6/l
31199.9
94194.5
1.38
64
191
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
39
50
7.88
28.52
1.7
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
277
1363
2.13
28.43
5.6
3.9
mmol/l
24.5
24.1
1.14
257
1217
(3017732) Neutrophils [#/volume] in Blood
327
1714
2.01
28.30
3.2
3.2
e9/l
4.1
4.2
0.12
241
1300
(3022948) Iron [Moles/volume] in Serum or Plasma
663
4323
1.67
28.03
2.4
2.5
umol/l
12.1
12.9
2.02
626
4009
(3026782) Osmolality of Urine
798
5455
1.62
27.96
3.0
2.8
mosm/kgh2o
553.6
553.3
0.01
719
4644
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1116
8273
1.54
27.34
3.0
2.6
u/l
54.2
57.7
1.37
1041
7606
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
246
1178
2.18
27.04
3.2
1.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
168
681
2.55
27.01
1.2
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
167
687
2.51
26.03
2.2
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2803
25530
1.80
25.70
35.1
15.3
mg/l
25.2
25.3
0.05
2584
20410
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
218
1015
2.23
25.67
2.1
3.3
u/ml
327.9
5157.7
1.06
165
866
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1102
8241
1.51
25.48
6.2
3.2
u/l
34.0
38.5
0.94
1058
7826
(3019832) Treponema pallidum Ab [Presence] in Serum
307
1636
1.97
25.26
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
655
4372
1.63
24.91
3.2
3.0
e6/l
1.8
2.1
0.54
375
2410
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
956
6970
1.53
24.75
2.1
2.2
mg/l
3.4
3.0
3.62
829
5899
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
428
2553
1.78
24.71
2.3
2.2
g/l
0.2
0.2
4.20
399
2373
(3019225) pH of Specimen
455
2773
1.75
24.36
7.5
4.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
161
676
2.45
24.03
1.6
1.4
iu/l
23.7
26.9
0.54
131
566
(3025941) Bacteria identified in Stool by Culture
261
1339
2.03
23.88
1.4
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
70
183
3.89
23.73
1.3
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
132
508
2.67
23.59
1.8
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
323
1795
1.89
23.40
4.8
3.9
ph
7.4
7.4
2.04
43
222
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
28
31
9.10
22.96
1.2
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
763
5368
1.55
22.95
4.5
3.8
ng/l
445.2
611.6
0.24
653
4377
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
143
584
2.52
22.65
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
143
584
2.52
22.65
1.5
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
311
1727
1.89
22.56
4.8
3.9
mmol/l
2.3
1.8
1.66
255
1261
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
323
1816
1.87
22.54
4.8
3.9
kpa
5.1
5.2
1.27
309
1683
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
98
330
3.03
22.43
2.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
98
330
3.03
22.43
2.5
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
163
711
2.36
22.36
5.1
3.6
mg/l
1.5
1.6
0.92
154
645
(3005988) Vibrio sp identified in Specimen by Organism specific culture
98
332
3.01
22.20
2.5
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
30
38
7.96
22.15
1.8
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
30
38
7.96
22.15
3.5
5.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
675
4661
1.57
21.92
3.2
2.8
e6/l
1.0
1.1
0.60
394
2684
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
39
67
5.88
21.81
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
97
332
2.98
21.59
2.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
98
338
2.96
21.52
2.5
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
34
52
6.60
21.29
1.4
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
136
560
2.49
21.18
1.9
1.4
e6/l
53.0
25.4
0.30
107
433
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
136
560
2.49
21.18
1.9
1.5
e6/l
629.5
641.4
0.01
109
458
(3024522) Salmonella sp identified in Specimen by Organism specific culture
97
336
2.95
21.14
2.5
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2079
17966
1.45
21.11
5.0
4.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
27
32
8.50
21.01
1.2
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
167
757
2.27
20.96
1.6
1.6
iu/ml
0.4
10.1
0.64
41
151
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
105
382
2.81
20.93
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
37
63
5.93
20.88
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
148
640
2.38
20.71
1.8
1.3
mg/l
520.8
547.4
0.32
139
599
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1305
10401
1.43
20.51
4.5
3.8
ng/l
46.1
95.3
0.58
1050
7547
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
214
1081
2.05
20.40
2.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
453
2895
1.66
20.11
5.3
3.5
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
45
95
4.79
20.10
1.7
1.5
%
1.1
2.5
0.93
38
82
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
75
230
3.32
20.09
1.7
1.5
nmol/l
0.3
0.3
0.29
67
183
(3036481) Cortisol [Moles/volume] in Serum or Plasma
382
2345
1.71
19.71
2.7
2.2
nmol/l
365.9
369.6
0.14
361
2133
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
136
588
2.37
19.05
2.2
1.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
48
113
4.30
18.77
1.6
1.5
%
65.3
63.2
0.13
40
90
(3001964) Herpes simplex virus Ag [Presence] in Specimen
38
74
5.18
18.62
1.3
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
16
10
16.08
18.51
1.2
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
240
1318
1.89
17.95
5.2
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
392
2482
1.66
17.93
5.8
7.0
mmol/l
1.5
1.4
1.22
385
2388
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
51
131
3.94
17.78
2.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
51
131
3.94
17.78
2.1
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
293
1722
1.77
17.57
2.0
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
81
284
2.90
17.33
1.8
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
142
653
2.23
17.25
5.3
4.7
mmol/l
2.9
2.6
0.52
115
451
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
210
1118
1.94
17.24
5.5
4.1
mmol/l
25.7
24.8
4.26
201
1043
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
146
680
2.20
17.19
1.3
1.3
—
15.4
—
0
15
(3035933) Granulocytes/100 leukocytes in Blood
31
54
5.79
17.11
3.4
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
519
3554
1.55
17.07
8.4
6.9
mmol/l
104.2
104.3
0.17
504
3470
(3009871) Measles virus Ab [Titer] in Serum
35
69
5.12
16.93
1.9
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1305
10652
1.38
16.79
3.1
2.8
ug/l
352.4
143.7
13.81
1216
9748
(3026008) Bacteria identified in Urine by Culture
1027
8060
1.40
16.69
3.1
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1276
10400
1.38
16.47
2.3
2.2
nmol/l
76.1
77.9
1.41
1176
9216
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
68
223
3.09
16.37
1.1
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
15
11
13.70
15.92
1.8
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
58
176
3.34
15.86
2.1
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
57
174
3.32
15.44
2.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
79
292
2.75
15.36
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
73
260
2.85
15.22
1.2
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
15
12
12.55
15.14
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
122
568
2.19
14.42
1.8
1.3
mmol/l
3.8
3.8
0.03
111
530
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
29
56
5.22
14.37
1.3
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
90
368
2.49
14.31
1.9
2.5
u/ml
463.1
757.7
0.14
90
355
(3016018) Differential panel - Cerebral spinal fluid
71
258
2.79
14.28
1.8
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
90
369
2.48
14.23
2.1
2.6
—
—
—
0
0
(3035880) pH of Pleural fluid
53
163
3.29
14.22
1.4
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2300
20824
1.37
13.92
38.1
18.6
%
14.3
13.7
46.15
2276
20322
(3010421) pH of Blood
150
768
2.00
13.81
5.2
4.4
ph
7.4
7.4
3.05
140
644
(1616796) Gas panel - Central venous blood
132
645
2.09
13.80
4.5
3.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
66
235
2.85
13.80
1.2
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
142
714
2.03
13.75
3.0
2.5
%
220.3
193.0
2.86
136
680
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
367
2436
1.57
13.69
2.5
2.4
u/l
34.9
39.0
0.65
313
2086
(3024980) IgG subclass 4 [Mass/volume] in Serum
90
378
2.42
13.53
1.4
1.6
g/l
0.7
0.9
0.89
67
286
(3027135) IgG subclass 1 [Mass/volume] in Serum
65
233
2.83
13.43
1.4
1.4
g/l
6.5
6.8
0.20
46
163
(3024139) IgG subclass 3 [Mass/volume] in Serum
65
233
2.83
13.43
1.4
1.4
g/l
0.4
0.4
0.20
46
163
(3028192) IgG subclass 2 [Mass/volume] in Serum
65
233
2.83
13.43
1.4
1.4
g/l
2.3
3.0
1.59
47
162
(3007853) Bacteria identified in Skin by Aerobe culture
451
3147
1.50
13.37
1.9
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
66
241
2.78
13.18
2.2
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
374
2516
1.55
13.13
3.4
3.0
ng/l
286.4
204.4
2.33
351
2294
(40768443) Skin Pathology biopsy report
200
1152
1.79
12.83
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
188
1063
1.82
12.83
2.4
3.5
u/ml
89.4
61.4
0.74
182
1026
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
21
33
6.40
12.82
1.9
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
21
33
6.40
12.82
1.9
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
33
6.40
12.82
1.9
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2589
24007
1.41
12.79
29.9
14.4
ml/min/173m2
79.3
78.4
1.36
2352
19823
(4062490)
64
235
2.76
12.66
1.5
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
122
600
2.07
12.56
2.6
3.4
u/ml
992.9
802.5
0.08
105
554
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
67
258
2.63
12.10
1.2
1.2
u/l
49.8
58.8
0.80
45
177
(3013862) HLA-DP [Type]
17
8
21.35
12.00
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
111
539
2.10
11.84
1.5
1.7
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
21
36
5.87
11.79
1.9
3.5
ng/l
105.4
84.8
0.35
15
21
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
12
10
12.04
11.74
1.5
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
94
432
2.21
11.53
1.2
1.2
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
23
44
5.26
11.53
1.8
1.6
%
7.7
5.2
0.26
12
22
(40760410) HLA-B [Type] by High resolution
16
8
20.09
11.12
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
16
8
20.09
11.12
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
16
8
20.09
11.12
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
16
8
20.09
11.12
1.0
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
488
3581
1.43
11.04
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
31
79
3.95
11.01
1.5
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
31
79
3.95
11.01
1.5
1.3
ug/l
5.9
463.5
0.74
14
39
(3042010) Triglyceride [Moles/volume] in Pleural fluid
23
46
5.03
10.99
1.3
1.2
mmol/l
4.3
1.6
0.99
17
35
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
90
415
2.20
10.97
1.2
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
227
1421
1.64
10.77
1.6
1.3
u/ml
266.3
230.9
0.14
196
1305
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
13
14
9.32
10.76
2.5
5.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
118
608
1.98
10.74
3.0
2.4
%
15.4
16.1
0.84
57
312
(3006922) Hepatitis E virus Ab [Presence] in Serum
46
155
3.00
10.68
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
31
81
3.85
10.65
1.0
1.0
—
—
—
0
0
(3013512) EKG study
969
7963
1.31
10.59
5.2
4.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
23
48
4.82
10.48
1.8
1.1
—
—
—
0
0
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
10
0
+∞
10.42
1.0
0.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
23
49
4.72
10.23
1.9
1.4
—
—
—
0
0
(3036489) Thrombin time
165
963
1.75
10.16
2.7
2.1
s
22.3
21.6
0.54
156
864
(3048879) Bone marrow aspiration report
31
85
3.67
9.97
1.9
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
45
157
2.89
9.85
2.2
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
2008
18199
1.28
9.80
4.8
4.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
130
717
1.85
9.67
1.5
1.5
g/l
1.2
1.2
0.02
125
681
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
126
689
1.86
9.63
1.5
1.5
g/l
0.2
0.2
0.14
118
657
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
11
11
10.03
9.54
1.6
1.3
mg/l
1.0
3.2
—
5
5
(3024354) Oxygen [Partial pressure] in Venous blood
315
2195
1.48
9.30
4.3
3.1
kpa
4.8
4.6
0.76
304
2118
(3019550) Sodium [Moles/volume] in Serum or Plasma
2794
26569
1.41
9.27
33.8
18.0
mmol/l
139.4
139.6
5.47
2748
25858
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1807
16225
1.26
9.27
3.9
3.2
u/l
59.6
52.9
2.13
1689
14943
(3037522) Nuclear Ab [Titer] in Serum
432
3208
1.40
9.04
1.3
1.3
titre
663.0
538.0
0.51
94
688
(3052851) Hemolysis interference index of Serum or Plasma
141
815
1.76
9.01
3.4
3.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
63
273
2.33
8.96
1.1
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
12
5
24.07
8.90
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
41
144
2.87
8.90
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
41
144
2.87
8.90
1.1
1.0
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
120
665
1.84
8.82
3.1
3.5
kpa
8.0
8.1
0.17
109
614
(3006184) Hemoglobin [Mass/volume] in Capillary blood
115
631
1.85
8.73
2.5
2.1
g/l
122.5
128.9
1.41
77
459
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
22
52
4.25
8.65
1.9
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
434
3254
1.39
8.56
7.2
7.3
mmol/l
1.4
1.1
0.91
337
2547
(3023103) Potassium [Moles/volume] in Serum or Plasma
2793
26627
1.39
8.50
34.5
18.1
mmol/l
4.0
4.0
0.26
2744
25882
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
56
236
2.40
8.49
1.4
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
85
426
2.02
8.43
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
127
728
1.78
8.37
1.3
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
432
3257
1.38
8.23
7.0
7.3
kpa
5.0
5.1
1.56
403
3098
(3027801) Oxygen [Partial pressure] in Arterial blood
432
3258
1.38
8.21
7.0
7.3
kpa
11.8
12.1
0.40
408
3102
(3024891) Influenza virus A+B Ag [Presence] in Specimen
112
623
1.83
8.16
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
127
738
1.75
8.00
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
98
529
1.88
7.86
1.7
2.3
u/l
2786.3
4579.0
0.48
34
221
(42529406) Shigella sp [Presence] in Stool by Culture
127
743
1.74
7.82
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
211
1407
1.53
7.70
3.0
3.3
pmol/l
4.3
4.4
1.30
190
1220
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
134
2.78
7.64
1.1
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2827
27090
1.38
7.58
22.1
10.7
u/l
26.9
26.5
0.34
2778
26013
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
90
480
1.90
7.51
1.2
1.2
u/l
129.8
42.5
1.23
77
412
(3019309) Folate [Moles/volume] in Red Blood Cells
655
5315
1.29
7.48
1.7
1.8
nmol/l
1173.7
1167.7
0.05
513
3977
(3021901) Oxygen saturation in Capillary blood
98
539
1.84
7.44
3.0
3.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
21
54
3.91
7.42
1.2
1.2
mmol/l
1.4
1.7
0.60
15
38
(3019060) Gas panel - Arterial blood
271
1917
1.45
7.41
5.6
4.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
390
2951
1.37
7.24
7.5
7.6
%
95.3
95.5
0.35
375
2829
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
41
163
2.54
7.09
1.7
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
64
309
2.09
7.08
1.5
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
124
745
1.69
6.98
3.2
3.7
mmol/l
24.5
24.9
0.44
106
650
(44786800) Granulocytes/100 leukocytes in Body fluid
16
35
4.59
6.93
1.6
1.5
%
20.9
16.1
—
10
24
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2055
19006
1.23
6.92
4.4
3.9
pmol/l
15.0
14.9
0.74
1894
17063
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
41
165
2.50
6.92
1.7
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2425
25521
0.79
6.90
4.7
5.1
mmol/l
2.6
2.7
0.80
2178
23256
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
284
2056
1.42
6.86
3.4
4.0
ng/l
79.8
93.6
2.01
238
1778
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
466
3661
1.32
6.71
1.4
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
480
3788
1.31
6.70
24.2
26.9
inr
1.3
1.4
0.48
76
538
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2347
24763
0.80
6.63
4.3
4.5
mmol/l
1.4
1.4
10.69
2115
22537
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
36
139
2.61
6.62
6.1
6.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
39
157
2.50
6.59
3.8
3.8
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
11
9
12.26
6.58
2.1
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
170
1125
1.54
6.47
1.4
1.3
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
15
33
4.56
6.45
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
46
3.93
6.43
1.5
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
59
288
2.07
6.37
2.8
4.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
61
302
2.04
6.35
1.2
2.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
302
2241
1.38
6.32
4.3
4.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2236
23679
0.81
6.32
5.8
6.1
mmol/mol
40.3
40.3
0.02
2026
21706
(3011544) Albumin [Mass/volume] in Pleural fluid
13
26
5.02
6.22
1.1
1.2
g/l
14.7
16.0
0.30
13
20
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2378
24966
0.81
5.78
4.3
4.6
mmol/l
4.5
4.5
1.88
2159
22893
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
33
132
2.52
5.69
1.1
1.1
u/l
105.8
88.1
0.74
28
101
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
33
132
2.52
5.69
1.1
1.1
u/l
35.0
31.3
0.21
27
97
(3023183) Ammonium ion [Moles/volume] in Plasma
100
601
1.69
5.69
2.1
2.8
umol/l
34.0
37.6
0.66
82
502
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
34
139
2.46
5.61
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
34
139
2.46
5.61
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
98
590
1.68
5.55
1.1
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
244
1788
1.39
5.53
7.7
6.7
mmol/l
24.8
24.5
0.66
224
1664
(3000492) Spirometry study
302
2295
1.35
5.46
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1589
14518
1.19
5.43
3.0
2.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
28
106
2.66
5.40
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
98
595
1.67
5.38
1.2
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
20
63
3.19
5.31
1.9
2.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
39
175
2.24
5.26
1.4
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
36
156
2.32
5.26
1.5
1.6
u/l
3.8
6.6
0.83
17
78
(3003327) Ova and parasites identified in Stool by Light microscopy
116
742
1.58
5.19
2.0
1.7
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
17
49
3.48
5.17
1.1
1.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2806
27106
1.29
5.15
38.2
17.9
umol/l
82.4
80.7
1.51
2806
27095
(3002173) Hemoglobin [Mass/volume] in Arterial blood
345
2699
1.31
5.11
8.2
8.1
g/l
114.2
121.8
8.50
331
2597
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
574
6825
0.81
5.10
1.7
1.6
mmol/l
1.5
1.4
1.30
488
5670
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
9
9
10.02
5.02
1.8
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
43
207
2.09
4.90
5.4
5.0
u/ml
53.2
53.4
0.00
16
59
(3020393) Adenovirus Ag [Presence] in Stool
11
24
4.60
4.78
1.2
1.6
—
—
—
0
0
(3020891) Body temperature
163
1143
1.45
4.76
5.2
4.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1388
12633
1.17
4.72
3.9
3.7
estimate
0.0
0.0
0.00
326
2383
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
33
146
2.27
4.63
2.8
4.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
12
29
4.15
4.62
1.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
55
296
1.87
4.60
1.3
1.2
u/ml
37.4
46.2
—
7
15
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
7
5
14.03
4.57
1.0
1.0
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
9
11
8.20
4.56
2.2
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
58
319
1.83
4.54
1.3
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
179
1289
1.41
4.53
2.9
2.6
%
0.7
0.7
0.06
171
1229
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
75
447
1.69
4.48
2.7
3.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
750
6500
1.20
4.47
1.6
1.6
nmol/l
19.2
20.3
1.24
656
5501
(3034770) Mitochondria Ab [Titer] in Serum
104
674
1.56
4.45
1.2
1.2
—
1233.3
—
0
21
(3007566) Smooth muscle Ab [Titer] in Serum
104
674
1.56
4.45
1.2
1.2
titre
111.5
91.6
0.35
13
56
(21491868) Cryoglobulin [Mass/volume] in Serum
25
100
2.51
4.37
1.4
1.3
g/l
1.2
0.2
—
5
9
(4015189)
21
77
2.74
4.34
2.0
2.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
44
226
1.96
4.25
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
136
943
1.46
4.24
2.2
3.2
g/l
0.5
0.3
0.52
67
383
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
29
127
2.30
4.19
1.6
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
35
166
2.12
4.19
1.1
1.1
mg/l
344.5
288.9
0.40
30
142
(3003740) Influenza virus B Ag [Presence] in Specimen
55
307
1.81
4.14
1.4
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
207
1553
1.36
4.12
10.5
10.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
720
8219
0.84
4.06
2.9
3.0
—
—
—
0
0
(40758358) Immune stain study
8
10
8.02
4.06
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
47
3.20
4.05
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
50
273
1.84
4.04
3.5
3.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
19
69
2.76
4.01
1.4
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
26
111
2.35
3.99
1.4
6.8
mg/l
9328.8
60.2
0.48
20
80
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
82
518
1.60
3.95
1.3
1.2
u/ml
1.3
8.3
—
10
35
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
35
171
2.06
3.90
1.1
1.1
mg/l
55.6
40.7
0.52
29
139
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
11
7.29
3.86
2.4
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
307
1.77
3.85
1.4
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1377
12660
1.15
3.85
5.4
5.0
estimate
0.0
0.0
0.50
333
2425
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
199
1501
1.35
3.84
1.2
1.3
au/ml
121.2
53.9
—
5
61
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
269
2122
1.29
3.78
2.9
2.7
ml/min/173m2
61.8
63.7
0.32
105
875
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
103
2.34
3.66
1.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
14
45
3.12
3.65
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
781
6902
1.17
3.64
4.4
4.1
estimate
0.0
0.0
0.30
305
2298
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2409
23113
1.17
3.62
5.1
4.7
mu/l
2.1
2.1
0.24
2218
20898
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
217
0.28
3.62
1.3
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2720
26377
1.21
3.58
26.3
14.6
—
—
—
0
0
(3004451) EKG impression Narrative
29
138
2.11
3.49
1.1
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1386
12812
1.14
3.47
4.1
3.8
estimate
0.0
0.0
0.25
317
2334
(3047181) Lactate [Moles/volume] in Blood
125
889
1.42
3.47
7.8
6.4
mmol/l
1.5
1.3
0.80
104
776
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
919
8258
1.16
3.43
2.1
2.2
u/l
171.0
243.6
1.88
871
7711
(3009542) Hematocrit [Volume Fraction] of Blood
2378
22827
1.16
3.41
31.4
16.4
%
37.9
39.5
12.45
1609
15494
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
305
2478
1.26
3.40
2.2
2.4
ug/l
9.8
7.4
0.53
262
2175
(3014891) Appearance of Pleural fluid
13
42
3.10
3.37
2.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
158
1176
1.36
3.36
2.8
2.7
—
—
—
0
0
(4027681)
27
127
2.14
3.35
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
53
314
1.70
3.32
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
195
1502
1.32
3.30
8.4
9.6
mmol/l
24.4
24.3
0.07
183
1402
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
23
103
2.24
3.22
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
69
443
1.57
3.17
1.4
1.3
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
23
104
2.22
3.15
1.1
1.1
ng/l
4702.0
464.4
—
5
29
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
20
85
2.36
3.15
1.4
1.2
%
15.6
16.1
—
5
11
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
8
7.51
3.05
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
28
139
2.02
3.05
1.3
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2307
23918
0.87
2.96
4.0
4.1
mmol/l
1.3
1.3
2.45
2077
21601
(3018405) Lactate [Moles/volume] in Arterial blood
136
1014
1.36
2.90
4.0
3.6
mmol/l
1.4
1.4
0.02
129
999
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
9
6.68
2.86
1.0
1.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
72
479
1.51
2.86
1.3
1.2
u/ml
47.1
46.8
0.00
11
45
(3036603) Volume of Urine
31
164
1.90
2.85
1.5
1.5
ml
1876.7
1812.2
—
7
36
(3024928) Oxygen saturation in Venous blood
86
596
1.46
2.80
3.5
2.9
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
6
8.34
2.75
4.4
4.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
6
8.34
2.75
4.4
4.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1202
11139
1.13
2.70
2.0
2.0
pmol/l
91.3
93.9
1.13
680
5781
(3011325) HIV 1+2 Ab [Presence] in Serum
6
10
6.01
2.70
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
95
677
1.42
2.68
1.4
1.2
u/ml
47.3
40.9
0.09
12
35
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
22
105
2.10
2.68
2.1
2.6
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
19
4.22
2.67
1.3
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
19
4.22
2.67
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
137
1788
0.76
2.65
1.6
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
103
749
1.39
2.60
1.8
1.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
26
134
1.95
2.60
1.2
1.0
u/l
1.1
1.2
0.16
12
66
(40768793) Breast Pathology biopsy report
74
508
1.47
2.56
1.5
1.3
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
33
3.04
2.52
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
339
2878
1.20
2.52
1.4
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
17
75
2.27
2.50
3.8
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
54
814
0.66
2.45
1.3
1.7
mg/l
3.7
3.9
0.05
41
579
(3013293) Extractable nuclear Ab [Presence] in Serum
10
34
2.95
2.41
1.9
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
271
2263
1.22
2.40
3.4
3.5
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
12
5.01
2.40
1.2
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
71
2.26
2.34
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
668
6019
1.14
2.31
3.9
3.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
137
1750
0.77
2.29
1.3
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
20
99
2.03
2.26
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
87
632
1.39
2.25
1.4
1.2
u/ml
2.6
3.6
0.56
13
55
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
88
641
1.38
2.24
1.4
1.2
u/ml
3.4
10.0
1.43
16
95
(3043409) Potassium [Moles/volume] in Arterial blood
113
860
1.33
2.18
4.3
3.8
mmol/l
3.8
3.9
0.68
100
801
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
80
2.13
2.18
1.1
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
11
42
2.62
2.18
1.3
1.2
%
61.7
53.9
—
6
14
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
23
122
1.89
2.16
1.2
1.7
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
19
3.69
2.15
1.0
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
47
306
1.54
2.13
1.1
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
115
881
1.32
2.13
1.3
1.2
u/ml
5.4
1.3
—
9
67
(1002224) Polysomnography panel
62
882
0.70
2.13
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
95
2.01
2.10
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
84
616
1.37
2.08
3.5
3.6
mg/l
29.8
29.3
0.04
60
373
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
15
69
2.18
2.04
1.1
1.3
%
75.8
87.9
—
8
43
(3044927) Protein electrophoresis panel - Urine
45
294
1.54
2.03
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
26
3.08
2.01
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
123
960
1.29
2.01
1.1
1.1
u/ml
—
1.4
—
0
14
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
15
299
0.50
2.00
1.4
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
251
2123
1.20
1.99
2.1
2.2
nmol/l
12.1
12.8
0.59
235
1859
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
90
1190
0.75
1.98
1.3
1.4
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
15
70
2.15
1.98
1.1
1.1
%
79.8
87.6
—
8
43
(3043410) Blood group antigens tested for on Red Blood Cells
16
77
2.08
1.96
5.1
2.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
49
329
1.50
1.96
7.3
6.4
mmol/l
7.0
7.5
0.65
39
277
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
33
2.73
1.93
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
800
8666
0.90
1.92
4.1
4.0
mg/mmol
9.4
9.3
0.03
525
5534
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
78
2.06
1.90
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
146
1173
1.26
1.90
6.5
5.3
%
1.6
1.6
0.11
132
1089
(3005570) Glucose [Moles/volume] in Urine
41
268
1.54
1.86
1.5
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
72
2.09
1.86
1.4
1.1
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
20
107
1.87
1.86
21.9
31.6
ug/l
8.3
7.1
2.30
13
96
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
51
351
1.46
1.83
1.9
2.3
mg/l
27.2
21.0
0.42
16
84
(3041096) Erythrocytes [Presence] in Urine by Automated
734
6745
1.11
1.82
3.8
3.5
—
—
—
0
0
(3019977) pH of Arterial blood
27
160
1.69
1.81
5.4
2.7
ph
7.4
7.4
0.05
11
52
(3000570) Elastase.pancreatic [Mass/mass] in Stool
101
780
1.30
1.81
1.5
1.5
ug/g
285.0
280.3
0.09
61
473
(3012516) Albumin [Mass/volume] in Urine
759
8221
0.90
1.81
3.3
3.3
mg/l
542.5
289.9
0.74
495
5282
(3025130) Human papilloma virus identified in Specimen
33
208
1.59
1.76
1.8
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1034
9694
1.10
1.72
4.3
4.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
27
163
1.66
1.71
1.1
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
12
55
2.19
1.67
1.1
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
19
3.16
1.66
1.0
1.2
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
7
25
2.80
1.65
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
69
2.03
1.64
1.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
76
1.98
1.64
1.4
1.1
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
84
643
1.31
1.63
9.7
7.3
mmol/l
103.8
105.4
2.08
73
566
(3039000) Anion gap in Blood
84
643
1.31
1.63
9.7
7.3
mmol/l
11.3
11.4
0.07
73
566
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
91
1.87
1.60
1.1
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
66
489
1.36
1.60
1.4
1.4
mmol/l
62.0
63.0
0.07
59
390
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
632
5802
1.11
1.60
1.6
1.7
pmol/l
442.0
26865469.6
4.13
527
4772
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
32
2.50
1.59
4.3
4.8
ug/min
45.4
71.2
—
8
26
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
63
2.07
1.59
2.5
2.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
70
2.00
1.59
1.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
6
20
3.00
1.58
4.3
3.4
g/mol
12.5
41.8
—
6
20
(3007930) Methemoglobin/Hemoglobin.total in Blood
141
1158
1.23
1.56
7.3
5.4
%
0.9
0.9
0.04
129
1077
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
379
3385
1.14
1.53
11.2
7.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
34
504
0.67
1.53
1.6
1.4
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
5
15
3.34
1.52
1.4
1.3
ng/l
5854.6
3601.6
—
5
9
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
21
2.86
1.50
2.0
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
806
8622
0.91
1.47
3.1
3.2
mmol/l
7.3
7.5
0.86
653
7213
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
25
155
1.62
1.46
1.8
1.6
g/l
0.9
1.0
0.62
25
155
(3008295) Osmolality of Serum or Plasma
42
293
1.44
1.46
1.1
1.3
mosm/kgh2o
280.8
277.9
0.37
33
215
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
87
1.84
1.45
1.1
1.1
miu/ml
993.4
1538.3
1.26
16
87
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
29
187
1.56
1.45
1.1
1.3
mmol/l
11.3
12.4
0.48
11
59
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
73
1.92
1.43
1.1
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
20
118
1.70
1.41
1.1
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
25
157
1.60
1.40
2.7
2.1
umol/l
8.6
26.2
—
5
13
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
22
349
0.63
1.38
1.2
1.1
u/ml
2.9
1.9
—
9
146
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
17
2.94
1.36
10.8
6.8
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
9
42
2.15
1.33
2.0
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
48
350
1.38
1.33
2.9
2.5
—
—
—
0
0
(4281824)
35
241
1.46
1.32
1.1
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
34
2.36
1.29
1.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
28
185
1.52
1.29
1.2
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
132
0.45
1.28
1.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
12
62
1.94
1.27
2.6
2.4
mmol/l
6.7
8.1
—
6
32
(3017704) Immunofixation for Urine
26
170
1.53
1.25
1.3
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
97
1186
0.81
1.23
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
44
321
1.38
1.23
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
78
1.80
1.21
1.0
1.1
—
—
—
0
0
(4212803)
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
39
2.05
1.15
1.0
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
20
304
0.66
1.09
1.1
1.1
u/ml
0.5
2.1
—
7
133
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
32
2.19
1.08
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
18
279
0.64
1.07
1.2
1.1
u/ml
0.1
2.4
—
5
70
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
807
8526
0.93
1.07
4.0
4.4
%
21.7
21.9
0.09
384
4261
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
97
1.65
1.06
2.6
2.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
53
678
0.78
1.04
1.2
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
118
1001
1.19
1.02
2.4
2.3
ug/l
522.1
527.8
0.01
107
941
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
17
263
0.64
1.01
2.3
1.7
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
53
1.89
1.01
1.6
1.2
nmol/l
32.4
30.1
—
10
42
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
156
1785
0.87
0.98
1.7
1.9
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
29
0.00
0.97
0.0
2.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.3
—
142.0
—
0
14
(3007461) Platelets [#/volume] in Blood
2850
28187
1.10
0.97
47.1
22.5
e9/l
230.4
245.0
20.91
2801
27383
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
34
250
1.36
0.95
1.3
1.3
nmol/l
1.2
1.4
0.73
27
222
(3048689) Calprotectin [Mass/mass] in Stool
310
2827
1.11
0.94
2.2
2.3
ug/g
201.4
153.8
1.00
253
2220
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
51
1.77
0.94
1.1
2.2
mmol/l
1.2
1.2
—
9
51
(3035320) C reactive protein [Mass/volume] in Body fluid
26
183
1.42
0.93
1.7
2.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
2850
28196
1.10
0.93
46.9
22.4
fl
91.6
91.3
2.90
2818
27717
(3035941) MCH [Entitic mass]
2850
28196
1.10
0.93
46.8
22.3
pg
30.4
30.4
0.39
2818
27714
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
235
2608
0.89
0.93
1.7
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2850
28198
1.10
0.92
47.1
22.4
e12/l
4.3
4.5
76.81
2798
27300
(3034426) Prothrombin time (PT)
13
78
1.67
0.91
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
42
541
0.77
0.90
1.6
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
2850
28205
1.10
0.89
47.3
22.6
g/l
127.8
135.2
102.11
2820
27727
(3010813) Leukocytes [#/volume] in Blood
2850
28206
1.10
0.89
47.1
22.5
e9/l
6.8
6.8
0.14
2799
27302
(3050129) First trimester maternal screen panel - Serum or Plasma
30
404
0.74
0.88
1.2
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
22
312
0.70
0.88
1.1
1.1
u/ml
4.8
4.8
0.00
12
156
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
175
1965
0.88
0.86
1.8
2.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
187
1.39
0.85
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
187
1.39
0.85
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
187
1.39
0.85
1.2
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
137
1.46
0.84
2.5
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
55
443
1.25
0.83
1.8
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
68
563
1.21
0.81
1.5
1.8
iu/l
6.5
4.7
0.31
15
185
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.79
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.79
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
26
190
1.37
0.79
1.2
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
48
1.67
0.78
7.6
8.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
0.2
—
0
8
(3027035) Albumin [Mass/time] in 24 hour Urine
0
28
0.00
0.76
0.0
1.3
—
720.0
—
0
8
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
162
1448
1.13
0.75
1.2
1.2
iu/ml
93.9
149.6
1.18
43
529
(3028300) Cannabinoids [Presence] in Urine
57
690
0.82
0.74
1.2
2.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
24
2.08
0.74
1.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
38
1.84
0.73
1.7
2.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
39
1.80
0.72
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
39
1.80
0.72
1.3
1.5
ng/l
116.3
130.8
—
7
39
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
12
76
1.58
0.71
1.3
2.3
%
211.1
175.3
0.49
12
68
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
7
40
1.75
0.71
1.4
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
40
1.75
0.71
8.4
6.7
—
—
—
0
0
(4268621)
32
247
1.30
0.70
2.1
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
217
0.69
0.70
1.2
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
85
1.53
0.69
1.2
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
57
681
0.83
0.67
1.2
2.1
—
—
—
0
0
(4024509)
32
249
1.29
0.67
1.7
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
13
86
1.51
0.66
1.3
2.0
—
—
—
0
0
(4010399)
165
1823
0.90
0.66
1.4
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
84
727
1.16
0.64
4.2
4.4
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
29
1.73
0.64
3.8
2.6
u/field
0.6
0.8
—
5
29
(3001019) Free T4 and TSH panel - Serum or Plasma
105
925
1.14
0.63
1.7
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
58
687
0.84
0.63
1.2
2.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
87
1.50
0.63
1.4
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
57
676
0.84
0.63
1.2
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
199
1.31
0.62
1.1
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
47
566
0.83
0.61
1.9
1.7
nmol/l
1.1
0.8
1.24
35
466
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
88
1.48
0.60
9.2
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
88
1.48
0.60
9.2
2.4
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
20
0.00
0.60
0.0
2.0
—
1.5
—
0
15
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
266
0.75
0.59
1.7
1.4
%
35.7
27.6
0.36
13
160
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
52
1.54
0.59
1.6
2.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
54
638
0.84
0.58
1.2
2.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
10
64
1.56
0.58
1.1
1.4
g/l
27.9
26.3
—
10
51
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2511
24832
1.05
0.57
4.9
4.8
mmol/l
6.0
6.0
1.67
2274
22372
(44816559) Phosphatidylethanol [Mass/volume] in Blood
36
441
0.81
0.57
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
71
615
1.16
0.56
1.6
1.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
24
185
1.30
0.56
1.2
1.4
—
223.9
—
0
18
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
37
1.62
0.55
1.8
2.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
74
1.49
0.53
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
62
1.45
0.53
2.3
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
72
629
1.15
0.52
2.8
3.1
nmol/l
0.9
0.8
0.38
48
475
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
68
778
0.87
0.51
1.4
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
21
270
0.78
0.51
1.5
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
135
1.34
0.51
1.1
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
85
753
1.13
0.51
1.6
1.8
nmol/l
46.1
40.8
1.29
85
722
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
225
0.75
0.50
1.6
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
20
153
1.31
0.50
1.5
2.2
—
—
—
0
0
(3016750) Collection duration of Urine
22
171
1.29
0.49
2.1
2.0
min
529.8
487.6
1.55
13
124
(3002619) Bacteria identified in Specimen by Culture
7
45
1.56
0.49
1.4
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
200
1862
1.08
0.47
1.1
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
152
1649
0.92
0.46
1.2
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
17
129
1.32
0.45
1.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
83
0.60
0.45
5.4
2.1
nmol/l
146.0
149.7
—
5
75
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
77
1.43
0.45
1.1
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
21
165
1.27
0.45
1.0
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
54
620
0.87
0.44
2.0
2.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
112
1.34
0.44
1.1
1.1
iu/ml
230.7
202.5
0.12
15
112
(3003338) MCHC [Mass/volume]
2130
21039
1.04
0.44
40.5
19.8
g/l
331.2
332.4
8.62
2112
20856
(3025018) Bordetella pertussis Ab [Titer] in Serum
16
121
1.32
0.44
1.1
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
31
1.61
0.43
1.2
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
190
1776
1.07
0.42
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
70
1.43
0.41
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
29
240
1.21
0.41
2.4
2.2
u/field
1.5
2.0
0.31
16
92
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.4
—
347.4
—
0
17
(3003129) Base excess in Capillary blood by calculation
11
79
1.39
0.40
2.5
1.9
mmol/l
1.6
1.0
0.21
11
74
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
67
747
0.89
0.37
1.6
1.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
68
1.32
0.37
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
19
233
0.81
0.34
1.1
1.1
u/ml
0.4
4.0
—
9
89
(3004616) Nuclear Ab [Presence] in Serum
36
311
1.16
0.34
1.5
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
37
322
1.15
0.32
1.2
1.3
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
155
1.23
0.32
2.4
2.1
ug/min
318.6
142.1
—
5
38
(1001926) Buprenorphine [Presence] in Urine by Screen method
48
539
0.89
0.32
1.2
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1046
10662
0.97
0.32
4.6
5.1
ug/l
3.4
3.8
0.18
929
9514
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
211
1.19
0.31
1.3
2.0
umol/l
4.2
10.2
1.16
13
138
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
371
3847
0.96
0.31
1.2
1.2
u/ml
9.8
12.4
0.37
114
1449
(3037556) Urate [Mass/volume] in Serum or Plasma
7
96
0.73
0.30
1.4
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
597
6134
0.97
0.30
2.8
3.1
ug/l
0.8
0.8
0.10
398
4191
(3041806) Other cells [#/volume] in Blood by Manual count
7
56
1.25
0.29
1.3
1.6
—
—
—
0
0
(4133840)
7
56
1.25
0.29
1.4
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
10
130
0.77
0.29
2.5
2.2
umol/l
49.5
53.4
—
10
102
(3045716) Anion gap in Serum or Plasma
11
140
0.78
0.28
1.3
2.3
mmol/l
11.2
9.5
—
6
113
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
62
1.29
0.28
7.5
7.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
122
1.23
0.27
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
35
309
1.13
0.27
1.1
1.3
nmol/l
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
28
243
1.15
0.26
1.7
2.0
—
1.3
—
0
11
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
70
760
0.92
0.26
1.7
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
40
447
0.89
0.26
1.9
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
11
86
1.28
0.26
3.1
2.1
ug/l
1.5
1.4
0.07
11
78
(3029075) Extractable nuclear Ab panel - Serum
10
77
1.30
0.26
1.2
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
74
1.22
0.25
7.3
7.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
41
368
1.12
0.25
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
147
1395
1.06
0.25
3.7
3.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
91
973
0.93
0.24
1.6
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
68
628
1.08
0.24
1.0
1.1
u/ml
3.1
5.6
—
9
61
(3044007) Cell count panel - Peritoneal fluid
9
77
1.17
0.24
1.3
2.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
10
78
1.28
0.24
1.0
1.9
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
124
1.21
0.24
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
13
158
0.82
0.23
1.8
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
31
275
1.13
0.23
1.4
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
39
1.28
0.23
1.2
1.4
—
—
—
0
0
(44806420)
7
92
0.76
0.22
1.7
2.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
337
0.89
0.22
1.7
1.6
%
64.6
62.2
0.14
21
208
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
268
2772
0.96
0.22
1.6
1.8
%
1.5
1.5
0.09
233
2398
(3047352) Trisomy 18 risk [Likelihood] in Fetus
31
276
1.12
0.22
1.4
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
11
0.00
0.21
0.0
6.2
—
421.8
—
0
11
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
10
0.00
0.21
0.0
7.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.3
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
2.4
—
0
12
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
293
3022
0.97
0.21
1.4
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
98
1.23
0.21
1.0
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
220
1.14
0.21
2.7
2.6
%
10.9
11.0
0.05
25
220
(3006270) Folate [Moles/volume] in Blood
25
220
1.14
0.21
1.1
1.2
nmol/l
393.7
357.8
0.41
20
186
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
29
258
1.13
0.21
1.2
1.1
%
86.7
94.5
0.82
29
243
(3013762) Body weight Measured
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
365
1.10
0.19
1.2
1.2
u/ml
3.4
3.2
—
8
125
(3019150) Specific gravity of Urine by Refractometry
566
5551
1.02
0.19
4.3
4.1
kg/l
1.0
1.0
0.24
94
842
(4094501)
76
715
1.06
0.18
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
18
156
1.15
0.18
2.4
3.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
15
128
1.17
0.18
2.1
3.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
58
1.21
0.18
1.3
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
75
707
1.06
0.18
2.3
2.3
ug/min
122.4
110.1
0.10
38
428
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
195
0.87
0.17
1.2
1.4
pmol/l
52.6
209.6
—
8
62
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
91
1.21
0.17
1.2
2.2
ug/l
289.0
111.1
0.26
11
80
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
289
0.90
0.17
1.2
1.3
mmol/l
7.6
7.6
0.00
19
214
(3016038) Potassium [Moles/volume] in Urine
20
176
1.14
0.17
1.3
1.2
mmol/l
30.5
34.1
0.54
20
152
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
301
1.10
0.17
1.1
1.0
u/ml
2.0
2.5
0.32
12
115
(4198724)
6
78
0.77
0.15
1.2
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
48
448
1.07
0.15
1.4
3.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
80
0.75
0.15
5.0
4.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
307
0.91
0.15
1.2
2.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
31
284
1.09
0.15
1.5
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
9
82
1.10
0.15
1.2
1.2
g/l
0.3
0.3
—
9
66
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
188
1.12
0.14
1.5
1.4
promille
1.0
1.1
0.12
13
147
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
22
198
1.11
0.14
1.7
1.9
nmol/l
20.5
18.5
0.39
22
183
(3000034) Microalbumin [Mass/volume] in Urine
28
256
1.09
0.14
2.7
3.1
mg/l
23.6
28.9
0.17
23
194
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
38
353
1.08
0.14
1.3
1.2
u/ml
1.8
5.0
2.82
15
160
(3017569) Oxygen content in Arterial blood
16
143
1.12
0.11
2.1
2.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
147
0.88
0.11
1.2
1.1
—
—
—
0
0
(4146454)
29
312
0.93
0.11
3.2
2.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
188
0.90
0.11
1.1
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
208
0.91
0.10
1.1
1.1
u/ml
1.3
4.6
—
9
82
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
12
106
1.13
0.09
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
69
717
0.96
0.09
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
41
390
1.05
0.08
1.6
1.6
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
65
0.77
0.08
1.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
66
1.06
0.08
1.0
2.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
43
411
1.05
0.08
1.1
1.1
iu/ml
1.6
80.6
—
7
83
(3006653) Thiamine [Moles/volume] in Blood
12
133
0.90
0.07
1.4
1.2
nmol/l
125.7
140.9
1.15
12
133
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
73
0.82
0.07
2.2
1.4
ug/l
6.8
9.1
—
6
73
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
343
3389
1.01
0.07
4.1
4.6
%
31.2
32.6
1.37
242
2236
(3004775) Volume in Urine collected for unspecified duration
25
235
1.06
0.07
2.3
2.2
ml
879.8
639.4
1.00
15
149
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
14
128
1.09
0.06
1.2
1.1
ratio
1.2
1.1
—
7
43
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
89
912
0.98
0.06
1.6
1.6
—
—
—
0
0
(4211845)
15
138
1.09
0.06
2.1
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
179
1763
1.02
0.06
3.2
3.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
162
0.93
0.06
3.5
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
25
237
1.06
0.05
3.4
2.7
%
13.6
13.2
1.23
25
237
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
139
1.08
0.05
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
64
657
0.97
0.05
2.0
1.7
e6/l
10102.2
14008.1
0.81
49
476
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
139
1411
0.98
0.05
2.3
2.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
337
1.04
0.04
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
337
1.04
0.04
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
338
1.04
0.04
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
338
1.04
0.04
1.3
1.4
—
—
—
0
0
(4306422)
35
338
1.04
0.04
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
25
261
0.96
0.04
1.7
1.3
e6/l
6752.8
93166.0
1.49
17
182
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
524
5213
1.01
0.04
1.2
1.2
u/ml
0.9
1.6
2.44
106
1323
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
402
4044
0.99
0.03
1.2
1.3
iu/ml
46.1
35.4
0.56
120
1262
(3051593) INR in Capillary blood by Coagulation assay
15
141
1.06
0.03
15.7
13.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
38
369
1.03
0.03
1.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
48
489
0.98
0.02
1.8
1.6
—
—
—
0
0
(4034850)
82
830
0.99
0.02
14.0
10.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
117
1163
1.01
0.00
1.9
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
34
344
0.99
0.00
1.2
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
10
102
0.98
0.00
1.7
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
63
634
0.99
0.00
1.4
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
208
1.01
0.00
1.6
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
10
97
1.03
0.00
1.5
1.2
%
49.0
59.1
—
10
82
(3020650) Glucose [Presence] in Urine
7
72
0.97
0.00
1.0
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
67
0.90
0.00
1.5
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
9
96
0.94
0.00
1.4
2.0
ug/l
46.1
60.9
—
9
91
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.6
—
0
5
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
7
76
0.92
0.00
1.0
1.2
umol/l
2.0
4.3
—
7
70
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
17
170
1.00
0.00
1.1
1.3
u/ml
1.5
0.9
—
5
85
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
7
0.00
0.00
0.0
6.6
—
86.0
—
0
7
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
100
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
7
76
0.92
0.00
2.6
1.4
pmol/l
14.9
14.8
—
7
63
(44813793)
15
150
1.00
0.00
1.1
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
33.1
—
0
7
(3012989) Citrate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
2.2
—
0
9
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
73
0.96
0.00
1.7
1.5
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2984.0
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
210
1.00
0.00
1.0
1.0
ng/l
1032.6
687.0
2.53
16
132
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
27.0
—
0
6
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
8
80
1.00
0.00
1.4
1.2
%
109.6
108.2
—
8
70
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.5
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LYMPHNODES_SECONDARY_NAS – Secondary and unspecified malignant neoplasm of lymph nodes
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).